Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 4,000 shares at $5.56 ($23K) on 2009-05-29, disclosed to the SEC on 2009-06-01.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.92 | 1,700 | $10K | 44.0% |
| 2 | $5.56 | 2,300 | $13K | 56.0% |
| Total | $5.71 avg | 4,000 | $23K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |